Nolvadex Falls To Generic Competition: AstraZeneca To Discontinue Tamoxifen

 
• By Todd Leeuwenburgh

AstraZeneca will pull its breast cancer therapy Nolvadex at the end of June.

More from Archive

More from Pink Sheet